Kane Biotech Inc.
KNBIF
$0.03
$0.006.40%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 67.30% | 60.28% | -43.75% | -56.04% | -66.41% |
| Total Receivables | -83.83% | -68.15% | 69.74% | -21.64% | -8.11% |
| Inventory | -52.23% | -53.86% | -38.87% | 37.82% | -8.77% |
| Prepaid Expenses | -- | -- | -- | 27.09% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -32.91% |
| Total Current Assets | -26.72% | 2.23% | -68.59% | -74.63% | -37.13% |
|
|
|||||
| Total Current Assets | -26.72% | 2.23% | -68.59% | -74.63% | -37.13% |
| Net Property, Plant & Equipment | -49.70% | -14.37% | -17.57% | -19.98% | -20.02% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -24.23% | -21.61% | -27.01% | -32.90% | -10.17% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -31.94% | -6.12% | -55.23% | -59.70% | -34.94% |
|
|
|||||
| Total Accounts Payable | 71.46% | 103.80% | 75.68% | 149.14% | 87.74% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -99.87% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 34.48% | 22.64% | 6.02% | -5.92% | -2.78% |
| Total Finance Division Other Current Liabilities | -- | -78.01% | -82.50% | -79.26% | -31.63% |
| Total Other Current Liabilities | -- | -78.01% | -82.50% | -79.26% | -31.63% |
| Total Current Liabilities | -34.70% | -30.01% | -82.40% | -79.70% | -71.31% |
|
|
|||||
| Total Current Liabilities | -34.70% | -30.01% | -82.40% | -79.70% | -71.31% |
| Long-Term Debt | 21.60% | 20.87% | -33.30% | -32.47% | -24.37% |
| Short-term Debt | -- | -- | -- | -- | -99.87% |
| Capital Leases | -55.43% | -14.56% | -19.11% | -20.57% | -12.73% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -25.39% | -15.33% | -76.10% | -73.14% | -64.68% |
|
|
|||||
| Common Stock & APIC | 6.53% | 12.53% | 2.62% | -4.46% | 4.48% |
| Retained Earnings | -6.47% | -10.33% | 22.88% | 25.03% | 17.69% |
| Treasury Stock & Other | -78.64% | -89.68% | -90.27% | -57.09% | -52.49% |
| Total Common Equity | -11.75% | 67.32% | 90.89% | 85.84% | 92.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.75% | 67.32% | 90.89% | 85.84% | 92.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -11.75% | 67.32% | 88.79% | 82.22% | 90.17% |
|
|
|||||